Double scan strategy aims to unlock prostate cancer secrets
NCT ID NCT06335914
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 30 men with advanced prostate cancer who will receive two different PET scans (PSMA and FDG) to see how their tumors behave at different stages and during treatment. The goal is not to treat the cancer directly, but to gather information that could help doctors choose better treatments and monitor responses in the future. Participants must have a specific type of advanced prostate cancer and be willing to undergo the scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection tame prostate cancer by cutting testosterone?
- Can a new drug combo slow advanced prostate cancer?
- Immunotherapy and hormone combo aims to tackle incurable prostate cancer
- Smart scans may slash radiation doses for metastatic prostate cancer
- Smart missile drug takes aim at Hard-to-Treat prostate cancer
- Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread